Jennifer Lynn Sherr MD, PhD
Instructor in Pediatrics (Endocrinology)
Departments & Organizations

2011 YCCI Scholars
Pediatrics: Pediatric Endocrinology: Children's Diabetes Program
Research Interests
type 1 diabetes; artificial pancreas; hypoglycemia; adjuncts to insulin therapy for type 1 diabetes; immune therapy more...
Education
- B.A., Rutgers College, 2000
- M.D., UMDNJ-New Jersey Medical School, 2003
- Ph.D., Yale Graduae School of Arts & Sciences, 2011
Selected Publications
- Sherr J, Xing D, Ruedy KJ, Beck RW, Kollman C, Buckingham B, et al. Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes. Diabetes care. 2013. Epub 2013/01/05.
- Herold KC, Gitelman SE, Willi SM, Gottlieb PA, Waldron-Lynch F, Devine L, Sherr J, Rosenthal SM, Adi S, Jalaludin MY, Michels AW, Dziura J, Bluestone JA. Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial. Diabetologia. 2013;56(2):391-400. Epub 2012/10/23.
- Weinzimer SA, Sherr JL, Cengiz E, Kim G, Ruiz JL, Carria L, et al. Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes care. 2012;35(10):1994-9. Epub 2012/07/21.



